Updated: Fri, 10/11/2024 - 12:00

Campus/building access, classes and work will return to usual conditions, as of Saturday, Oct. 12. See Campus Public Safety website for details.


Accès au campus et aux immeubles, cours et modalités de travail : retour à la normale à compter du samedi 12 octobre. Complément d’information : Direction de la protection et de la prévention.

Soham Rej

Academic title(s): 

Associate Professor

Soham Rej
Contact Information
Email address: 
soham.rej [at] mcgill.ca
Phone: 
514 340 8222 x 27506
Address: 

Dept. of Psychiatry
Jewish General Hospital/Lady Davis Institute
4333 Côte-Ste-Catherine Rm 144
Montréal, Qc, H3T 1E4

Degree(s): 

MD, MSc, FRCP(C)

Areas of expertise: 

Geriatric Psychiatry, Randomized Clinical Trials, Technology-Assisted Behavioral Interventions (Virtual Reality, Zoom, Sensors, Phenotyping, Robots), Mind-Body Interventions (Mindfulness, Meditation, Yoga, Tai Chi, Exercise, Health Education), Psychedelic Therapy, Late-Life Depression, Anxiety, and Dementia

Biography: 

Dr. Soham Rej completed his medical school (2009) and psychiatry residency at McGill (2014), followed by a geriatric psychiatry clinical and research fellowship at the University of Toronto (2017). He is currently an Associate Professor and Geriatric Psychiatrist at the Jewish General Hospital/Lady Davis Institute, McGill University, Montreal.

As of Oct 2024, he has 175 peer-reviewed publications, $3.2M in peer-reviewed research funding (CIHR, FRQS, etc.) and $2.1M in charitable, corporate, and governmental funding. He has mentored more than 90 graduate students, post-doctoral fellows, psychiatry residents, and other trainees, including 30 who are currently scientists at the assistant/associate professor level.

Major Research Activities:
Dr. Rej's research lab investigates:
a) Clinical trials to improve mood, anxiety, and cognitive disorders in older adults with three foci:
1. Mind-body Interventions (Mindfulness, Meditation, Tai Chi, Yoga, Exercise, Health Education);
2. Technology-Assisted Behavioral Interventions (e.g. Virtual Reality, Zoom);
3. Psychedelic-Assisted Psychotherapy (Ketamine, Psilocybin).

b) The Epidemiology of Older Age Bipolar Disorder using the Global Aging in Geriatric Bipolar Disorder Database (GAGE-BD). I am one of 4 main investigators for this project with n≥ 4500 participants, and >34 sites.

c) The Neuroscience of Expert Meditators.

 

Back to top